Headquarters
United States
team size
1 - 4
founded
2012
website
http://allovate.com/
funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
Offices
United States
HQ address
20 W 125 St, New York, 10027, USA
description
Allovate, LLC is a specialty biopharmaceutical company that is developing an improved approach to allergen-specific immunotherapy for the treatment of allergic diseases. Allergic diseases affect more than 25% of the global industrial population, at an annual cost in excess of $33 billion in the US alone. There is an enormous and growing unmet need for allergic disease modifying treatment options. Allovate’s mission is to expand the use of immunotherapy among the millions of global allergy sufferers by developing products that are safer, more effective, and easier to administer.

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats